CEECAT Capital

The firm runs a multi-strategy private equity mandate including control buyouts, growth equity, expansion capital, early-stage co-investments, and restructuring situations. Its focus is on mid-market companies in Central and Eastern Europe. The strategy spans both majority and minority positions depending on the deal structure.

CEECAT Capital is domiciled in Schuttrange, Luxembourg, and likely operates under the Alternative Investment Fund Managers Directive (AIFMD) framework. This structure allows the firm to market its funds across EU member states under a regulatory passporting regime. Luxembourg's AIFM structure is a common choice for managers targeting institutional investors across Europe.

The firm's investment focus is Central and Eastern Europe. This includes EU member states in the region as well as neighboring markets. The geographic concentration is the firm's defining structural feature, setting it apart from generalist pan-European managers.

Yes, the firm's strategy includes early-stage and seed-stage investments, typically executed as co-investments. These sit alongside control buyouts and expansion-stage growth deals. The early-stage allocation suggests the firm maintains relationships with local angel networks or venture ecosystems in its target region.

The firm explicitly lists restructuring as a core strategy, which indicates it actively pursues turnarounds, distressed buyouts, or operational improvement situations. Specific portfolio company restructurings have not been publicly disclosed. The restructuring capability suggests a team with operational and legal expertise in workouts.

The firm's founding principals have not been publicly identified in available records. CEECAT Capital operates without a visible public-facing leadership profile, which is not uncommon for Luxembourg-domiciled managers serving institutional limited partners. Further primary research would be required to identify the investment committee and key decision-makers.

The firm has not publicly disclosed its AUM. No recent regulatory filings or press reports have surfaced a specific figure. Allocators evaluating the firm would need to request this information directly during due diligence.